Cargando…

Clostridioides difficile S-Layer Protein A (SlpA) Serves as a General Phage Receptor

Therapeutic bacteriophages (phages) are being considered as alternatives in the fight against Clostridioides difficile infections. To be efficient, phages should have a wide host range, buthe lack of knowledge about the cell receptor used by C. difficile phages hampers the rational design of phage c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Royer, Alexia L. M., Umansky, Andrew A., Allen, Marie-Maude, Garneau, Julian R., Ospina-Bedoya, Maicol, Kirk, Joseph A., Govoni, Gregory, Fagan, Robert P., Soutourina, Olga, Fortier, Louis-Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100898/ https://www.ncbi.nlm.nih.gov/pubmed/36790200 http://dx.doi.org/10.1128/spectrum.03894-22

Ejemplares similares

A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor
por: Whittle, M. J., et al.
Publicado: (2022)

Receptor binding protein of prophage reversibly recognizes the low-molecular weight subunit of the surface-layer protein SlpA in Clostridioides difficile
por: Phetruen, Tanaporn, et al.
Publicado: (2022)

Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile
por: Merrigan, Michelle M., et al.
Publicado: (2013)

The long and sinuous road to phage-based therapy of Clostridioides difficile infections
por: Umansky, Andrew A., et al.
Publicado: (2023)

Purification and characterization of DR_2577 (SlpA) a major S-layer protein from Deinococcus radiodurans
por: Farci, Domenica, et al.
Publicado: (2015)

The C lostridium difficile cell wall protein CwpV confers phase‐variable phage resistance
por: Sekulovic, Ognjen, et al.
Publicado: (2015)

Type I toxin-antitoxin systems contribute to the maintenance of mobile genetic elements in Clostridioides difficile
por: Peltier, Johann, et al.
Publicado: (2020)

Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile
por: Boudry, Pierre, et al.
Publicado: (2015)

Erratum for Boudry et al., Function of the CRISPR-Cas System of the Human Pathogen Clostridium difficile
por: Boudry, Pierre, et al.
Publicado: (2015)

Phage therapy for Clostridioides difficile infection
por: Fujimoto, Kosuke, et al.
Publicado: (2022)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

In Vivo Targeting of Clostridioides difficile Using Phage-Delivered CRISPR-Cas3 Antimicrobials
por: Selle, Kurt, et al.
Publicado: (2020)

Bacteriophages Contribute to Shaping Clostridioides (Clostridium) difficile Species
por: Fortier, Louis-Charles
Publicado: (2018)

Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
por: Normington, Charmaine, et al.
Publicado: (2021)

Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
por: Venhorst, Jennifer, et al.
Publicado: (2022)

An intact S-layer is advantageous to Clostridioides difficile within the host
por: Ormsby, Michael J., et al.
Publicado: (2023)

A cortex-specific penicillin-binding protein contributes to heat resistance in Clostridioides difficile spores
por: Alabdali, Yasir Adil Jabbar, et al.
Publicado: (2021)

Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
por: Dong, Qiwen, et al.
Publicado: (2023)

Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile
por: Dong, Qiwen, et al.
Publicado: (2023)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Evidence for an Adaptation of a Phage-Derived Holin/Endolysin System to Toxin Transport in Clostridioides difficile
por: Mehner-Breitfeld, Denise, et al.
Publicado: (2018)

Protospacer-Adjacent Motif Specificity during Clostridioides difficile Type I-B CRISPR-Cas Interference and Adaptation
por: Maikova, Anna, et al.
Publicado: (2021)

Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

The small acid-soluble proteins of Clostridioides difficile are important for UV resistance and serve as a check point for sporulation
por: Nerber, Hailee N., et al.
Publicado: (2021)

Genome-Wide Transcription Start Site Mapping and Promoter Assignments to a Sigma Factor in the Human Enteropathogen Clostridioides difficile
por: Soutourina, Olga, et al.
Publicado: (2020)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

PhageTerm: a tool for fast and accurate determination of phage termini and packaging mechanism using next-generation sequencing data
por: Garneau, Julian R., et al.
Publicado: (2017)

Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam
por: Garneau, Julian R, et al.
Publicado: (2014)

Nectin-3 and shed forms of CSPG4 can serve as epithelial cell receptors for Clostridioides difficile TcdB
por: Childress, Kevin O., et al.
Publicado: (2023)

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile
por: Neumann-Schaal, Meina, et al.
Publicado: (2019)

Potential Role of the Host-Derived Cell-Wall Binding Domain of Endolysin CD16/50L as a Molecular Anchor in Preservation of Uninfected Clostridioides difficile for New Rounds of Phage Infection
por: Phothichaisri, Wichuda, et al.
Publicado: (2022)

Clostridioides difficile therapeutics: guidelines and beyond
por: Orenstein, Robert, et al.
Publicado: (2019)

Impact of ribotype on Clostridioides difficile diagnostics
por: Rizzardi, Kristina, et al.
Publicado: (2019)

Clostridioides (Clostridium) difficile Pacemaker Infection
por: Berkefeld, Anna, et al.
Publicado: (2020)

Opportunities for Nanomedicine in Clostridioides difficile Infection
por: Wang, Pei-Wen, et al.
Publicado: (2021)

Introduction to the Special Issue on Clostridioides difficile
por: Granata, Guido, et al.
Publicado: (2021)

Epidemiology of Clostridioides difficile in South Africa
por: de Jager, Pieter, et al.
Publicado: (2021)

The repertoire of ABC proteins in Clostridioides difficile
por: Pipatthana, Methinee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j9svn97a57lhkau31iefhdql87